Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
7.48
+0.03 (0.40%)
Feb 21, 2025, 4:00 PM EST - Market closed
Profound Medical Revenue
Profound Medical had revenue of $2.83M in the quarter ending September 30, 2024, with 63.89% growth. This brings the company's revenue in the last twelve months to $8.98M, up 39.35% year-over-year. In the year 2023, Profound Medical had annual revenue of $7.20M with 7.75% growth.
Revenue (ttm)
$8.98M
Revenue Growth
+39.35%
P/S Ratio
24.94
Revenue / Employee
$68,580
Employees
131
Market Cap
224.07M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.20M | 518.00K | 7.75% |
Dec 31, 2022 | 6.68M | -192.00K | -2.79% |
Dec 31, 2021 | 6.87M | -431.00K | -5.90% |
Dec 31, 2020 | 7.30M | 3.13M | 74.99% |
Dec 31, 2019 | 4.17M | 1.57M | 60.40% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
PROF News
- 8 days ago - Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow - GlobeNewsWire
- 6 weeks ago - Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues - GlobeNewsWire
- 6 weeks ago - Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares - GlobeNewsWire
- 2 months ago - Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares - GlobeNewsWire
- 2 months ago - Profound Medical Announces Proposed Public Offering of Common Shares - GlobeNewsWire
- 2 months ago - Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy - GlobeNewsWire
- 3 months ago - Profound Medical to Unveil Next TULSA-AI® Module, ‘UA Alignment Assistant' - GlobeNewsWire